Jianfeng Group Lin2016 -029 (Announcement on Progress of Subsidiary's Foreign Investment)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2016-029
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Progress of Subsidiary's Foreign Investment
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Basic Information on Foreign Investment in 1.
On July 12, 2016 , Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), a subsidiary of the Company, and Germany Gefu Pharmaceutical Co., Ltd. (hereinafter referred to as "Gefu Pharmaceutical"), Zhuhai Hengqin Deyunjia International Trade Co., Ltd. (hereinafter referred to: de Yunjia) signed the "Sino-foreign Joint Venture Contract" and jointly funded the establishment of a Sino-foreign joint venture in Jinhua City, Zhejiang Province, China, committed to building a pharmaceutical company for infants and children. The Chinese name of the joint venture company is: Zhejiang Jindel Baby Pharmaceutical Co., Ltd. The registered capital of the joint venture company is RMB 20 million, of which: Jianfeng Pharmaceutical contributed RMB 11 million in cash, Ge Fu Pharmaceutical contributed RMB 5 million in the evaluation of intellectual property rights of proprietary technology, and Deyunjia contributed RMB 4 million in cash.
For details, please refer to 2016 -Lin 2016-026 "Announcement on Foreign Investment of Subsidiaries" published by the company in the designated information disclosure media "shanghai securities news", "china securities journal" and the website of Shanghai Stock Exchange (www.sse.com.cn ) on July 13, 40.
Progress of 2. Foreign InvestmentAfter the signing of the Sino-Foreign Joint Venture Contract, the parties to the cooperation have applied to the relevant departments in accordance with relevant national laws, regulations and relevant government regulations and obtained the Approval Certificate for the People's Republic of China Foreign-invested Enterprises and the Business License.
The main registration items of the "Business License" are as follows:
Name: Zhejiang Jindel Baby Drug Co., Ltd.
Unified Social Credit Code: 91330700MA28E8DU4L
Type: Limited Liability Company (
Sino-foreign Joint Venture)
Domicile: legal Representative of, 3rd Floor, X02 Office Quality Inspection Building, No. 58
, Gaofan Section, Tangxi Town, Wucheng District, Jinhua City, Zhejiang Province: Jiang XiaomengRegistered Capital: RMB 20 Million Yuan
Date of Establishment: August 30, 2016
Business Term: 2016
from August 30 to August 29, 2046
Scope of business: drug research and development, drug production (see "Drug Production License" for the specific scope), drug business (see "Drug Business License" for the specific scope), import and export of health products. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)As of the date of this announcement, the cooperating parties have not yet made capital contributions.
3. Reference Document
Copy of Business License of Zhejiang Jindal Baby Pharmaceutical Co., Ltd. and Approval Certificate of the People's Republic of China Foreign Investment Enterprise.
hereby announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
September 2, 2016
More information
Peak re-listed China's top 100 cement production capacity Daye peak won the "smart factory leader"
On July 11-12, the 2022 China Cement Industry Summit and TOP100 Award Ceremony organized by China Cement Network, an authoritative media of China's cement industry, was held in Hangzhou. Jianfeng Group once again ranked among the top 100 cement clinker production capacity in China.
2022
08-04
On the afternoon of July 12, the party Committee of the group company held a special meeting attended by party Committee members, senior and middle-level management backbones, heads of grass-roots party organizations and all party members of the group headquarters to learn and convey the spirit of the 15th party congress of the communist party of China in Zhejiang province.
2022
07-24
On the morning of July 1, more than 40 members of the group's party committee, party members of various branches of the group headquarters, and party members of subordinate enterprise branches went to the Shuanglong Hydropower Station, the Red Education Base of Jinhua City, to receive party spirit and revolutionary tradition education.
2022
07-14
Vocational skill level identification examination!
On June 16 and 18, the theoretical and practical examinations for the determination of professional skill level in the peak pharmaceutical sector were held successively in Jinxi pharmaceutical factory. The independent identification of vocational skill level includes three occupations (types of work): pharmaceutical preparation worker, chemical inspector and organic synthesis worker, basically covering the main posts in the pharmaceutical sector, with a total of 125 employees signing up for the identification.
2022
06-21
On June 16, the Jianfeng Pharmaceutical Quality Research and Development Party Branch and the Jinhua Vocational Skills Management Service Center Party Branch held a signing ceremony in Jinxi Factory to establish a party building alliance.
2022
06-21
Jinhua Mayor Xing Zhihong to Peak Research
On the afternoon of June 1, Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng, District Mayor Hu Yuxian, and heads of the Municipal Economic and Information Bureau, Development and Reform Bureau and other departments went to the group headquarters to discuss and exchange with the leaders of the group company to understand the development of the enterprise. Solicit opinions and suggestions from enterprises on government work. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
2022
06-13